Paremyd

Product manufactured by Akorn, Inc.

Application Nr Approved Date Route Status External Links
NDA019261 None Ophthalmic None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications Paremyd ® Solution Is Indicated For Mydriasis In Routine Diagnostic Procedures And In Conditions Where Short-Term Pupil Dilation Is Desired. Paremyd ® Provides Clinically Significant Mydriasis With Partial Cycloplegia.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Comments